Pictet Asset Management (UK)’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $34.2M | Buy |
211,603
+78,547
| +59% | +$12.7M | 0.04% | 416 |
|
|
2021
Q1 | $22.8M | Sell |
133,056
-1,332
| -1% | -$228K | 0.03% | 476 |
|
|
2020
Q4 | $29.5M | Buy |
134,388
+53,465
| +66% | +$11.7M | 0.04% | 406 |
|
|
2020
Q3 | $13.4M | Sell |
80,923
-212
| -0.3% | -$35.2K | 0.02% | 494 |
|
|
2020
Q2 | $9.26M | Buy |
81,135
+22,862
| +39% | +$2.61M | 0.02% | 541 |
|
|
2020
Q1 | $4.48M | Sell |
58,273
-56,066
| -49% | -$4.31M | 0.01% | 670 |
|
|
2019
Q4 | $14.7M | Sell |
114,339
-153,095
| -57% | -$19.7M | 0.03% | 489 |
|
|
2019
Q3 | $20.8M | Buy |
267,434
+117,726
| +79% | +$9.17M | 0.04% | 374 |
|
|
2019
Q2 | $15.4M | Sell |
149,708
-86,267
| -37% | -$8.89M | 0.03% | 435 |
|
|
2019
Q1 | $17.3M | Buy |
235,975
+2,141
| +0.9% | +$157K | 0.04% | 417 |
|
|
2018
Q4 | $9.92K | Buy |
233,834
+42,305
| +22% | +$1.8K | 0.02% | 504 |
|
|
2018
Q3 | $9.02M | Buy |
+191,529
| New | +$9.02M | 0.02% | 577 |
|